Results 211 to 220 of about 4,861,792 (337)

The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses. [PDF]

, 1978
Juan Oliver, Paul J. Cannon
openalex   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi, Masaomi Nangaku, Tadashi Sofue, Tatsuo Kagimura, Ichiei Narita   +4 more
wiley   +1 more source

Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors. [PDF]

Molecules
Moore GJ, Ridgway H, Gadanec LK, Apostolopoulos V, Zulli A, Matsoukas JM.   +5 more
europepmc   +1 more source

Inhibitors of the renin‐angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting‐enzyme inhibitor. [PDF]

, 1979
JJ Morton, J. Casals‐Stenzel, A. F. Lever, JA Millar, A. J. G. Riegger, M. Tree   +5 more
openalex   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery. [PDF]

Catheter Cardiovasc Interv
Lucchelli M, Andreis DT, Gomarasca M, Mistraletti G.   +3 more
europepmc   +1 more source

Response of aldosterone and blood pressure to angiotensin II infusion in anephric man. Effect of sodium deprivation. [PDF]

, 1976
J Deheneffe, V. Cuesta, J. D. Briggs, J. J. Brown, R. Fräser, A. F. Lever, J. J. Morton, Iris Robertson, M. Tree   +8 more
openalex   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Beneficial Effects of Chymase Inhibition on Cardiac Diastolic Function and Remodeling Induced by Chronic Angiotensin II Stimulation. [PDF]

Int J Mol Sci
Taniguchi S, Jin D, Morihara H, Yokoe S, Moriwaki K, Takai S.   +5 more
europepmc   +1 more source

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Circulation, 2005
Carlos M. Ferrario, Jewell A. Jessup, M. Chappell, D. Averill, K. Brosnihan, E. Tallant, D. Diz, Patricia E. Gallagher   +7 more
semanticscholar   +1 more source